Abstract
Clostridium difficile has become the most common infectious cause of healthcare-associated diarrhea, with serious morbidity, prolonged hospitalization and even death. Treatment of the disease utilizing today’s therapies does not guarantee a successful outcome. In the past decade, many new ideas and inventions have surfaced exploring different treatment strategies of Clostridium difficile associated diarrhea (CDAD). These treatments include antitoxins, novel antimicrobials, immunoglobulins and large inert synthetic compounds. In this paper, we survey of a number of representative patents issued from 2000 to the present targeting treatment of this difficult and dreaded disease.
Keywords: Bacterial toxin, Clostridium difficile, drug target, patents.
Recent Patents on Anti-Infective Drug Discovery
Title:A Surview of Recent Patents on Anti-Infective Therapy for Clostridium difficile
Volume: 8 Issue: 2
Author(s): Germine S. Soliman, Bechoi Saleib and Stephen J. Scholand
Affiliation:
Keywords: Bacterial toxin, Clostridium difficile, drug target, patents.
Abstract: Clostridium difficile has become the most common infectious cause of healthcare-associated diarrhea, with serious morbidity, prolonged hospitalization and even death. Treatment of the disease utilizing today’s therapies does not guarantee a successful outcome. In the past decade, many new ideas and inventions have surfaced exploring different treatment strategies of Clostridium difficile associated diarrhea (CDAD). These treatments include antitoxins, novel antimicrobials, immunoglobulins and large inert synthetic compounds. In this paper, we survey of a number of representative patents issued from 2000 to the present targeting treatment of this difficult and dreaded disease.
Export Options
About this article
Cite this article as:
Soliman S. Germine, Saleib Bechoi and Scholand J. Stephen, A Surview of Recent Patents on Anti-Infective Therapy for Clostridium difficile, Recent Patents on Anti-Infective Drug Discovery 2013; 8 (2) . https://dx.doi.org/10.2174/1574891X113089990016
DOI https://dx.doi.org/10.2174/1574891X113089990016 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
Design, Preparation and Characterization of Modular Squalene-based Nanosystems for Controlled Drug Release
Current Topics in Medicinal Chemistry Sex Differences in Oxidative Stress Biomarkers
Current Drug Targets Homocysteine and Heart Failure: An Overview
Recent Patents on Cardiovascular Drug Discovery Recent Advances on the Roles of NO in Cancer and Chronic Inflammatory Disorders
Current Medicinal Chemistry Patient-Controlled Analgesia
Current Drug Targets Levosimendan Preoperative
Current Pharmaceutical Design Polyunsaturated Fatty Acids in Pregnancy and Metabolic Syndrome: A Review
Current Pharmaceutical Biotechnology Current and Future Treatment Options in Idiopathic Pulmonary Fibrosis
Inflammation & Allergy - Drug Targets (Discontinued) The Gut and Intestinal Bacteria in Chronic Heart Failure
Current Drug Metabolism Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Research
Current Pharmaceutical Design Neonatal Systemic Thrombosis: An Updated Overview
Current Vascular Pharmacology Propranolol Safety Profile in Children
Current Drug Safety Ontogenic Development and Population Dynamics of Hepatic Dendritic Cells
Current Immunology Reviews (Discontinued) Bone Marrow Microenvironment: A Newly Recognized Target for Diabetes- Induced Cellular Damage
Endocrine, Metabolic & Immune Disorders - Drug Targets Cardiomyopathy of Pregnancy
Current Women`s Health Reviews New Devices for Treating Acute Ischemic Stroke
Recent Patents on CNS Drug Discovery (Discontinued) Patents Review in siRNA Delivery for Pulmonary Disorders
Recent Patents on Drug Delivery & Formulation Pharmacological Properties of Indazole Derivatives: Recent Developments
Mini-Reviews in Medicinal Chemistry Entering the Era of Non-Basic P1 Site Groups: Discovery of Xarelto™ (Rivaroxaban)
Current Topics in Medicinal Chemistry Topical Applications of Ozone and Ozonated Oils as Anti-Infective Agents: An Insight into the Patent Claims
Recent Patents on Anti-Infective Drug Discovery